Aspen Global incorporated

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies branded, OTC, and generic pharmaceutical products, infant nutritionals, and consumer healthcare products. The company offers various branded products for a range of therapeutic categories, including anaesthetics, analgesics, anti-retrovirals, blood and haemopoetic, cardio vascular system, central nervous system, endocrine system, gastro-intestinal tract, infant milk formulations, musculo-skeletal agents, NSAids, oncology, oral hygiene, respiratory system, and urinary tract system, as well as ear, nose, and throat. It also provides various generics covering a range of categories, such as anti-depressants; analgesics for pain relief; anti-hypertensives for high blood pressure; bronchodilators for the treatment of asthma; anti-bacterials to treat bacterial infections; anti-gout agents; anti-inflammatory agents; anti-fungal agents; anti-histamines for the treatment of allergies; decongestants; gastro-intestinal agents; dermatologicals; and anti-retrovirals. In addition, the company manufactures narcotic and specialist fine active pharmaceutical ingredients. The company serves pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders, and retail stores across the private and public sectors. It has operations in South Africa, the Asia Pacific, Europe CIS, Latin America, Sub-Saharan Africa, the Middle East, North Africa, the United States, and Canada. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.